Home / News
Mission updates
Track strategic developments and technical progress from across the Axplora network. These include corporate announcements, expert insights, expansion news and industry updates.
News
March 17, 2026
Biopharma’s Growing Emphasis on Highly Potent Drugs Drives Axplora Manufacturing Expansion
Highly potent drugs now account for over 30% of the global pipeline, with more than 1,000 molecules in development — Axplora’s investments in HPAPI capacity help customers bring these complex therapies to market faster $60 million investment to expand highly potent API (HPAPI) development and manufacturing at Axplora’s Farmabios site in Gropello Cairoli, Italy New […]
News
March 17, 2026
Axplora announces multi-million-euro investment to expand lyophilization at Le Mans and appoints François Houbart as Head of Site
Axplora announces multi-million-euro investment to expand lyophilization at Le Mans and appoints François Houbart as Head of Site 18 February, 2026 – Axplora, a global CDMO Partner for complex small molecules and antibody-drug conjugates (ADCs), today announced a multi-million-euro investment to expand lyophilization (freeze-drying) capabilities at its Le Mans, France Site strengthening its ability to deliver […]
News
November 29, 2023
CPHI worldwide 2023 continuity: Interview with Arul Ramadurai, CCO
Discover Arul Ramadurai’s exclusive interview at CPHI worldwide 2023 and learn more about Axplora’s business vision! He talks about patients' security, sites’ audits and certifications, but also about Axplora’s Environmental, Social, and Governance (ESG) strategy and electrochemistry (...). As an emotion is worth a thousand words, we encourage you to enjoy the video!
News
November 21, 2023
CPHI 2023: Interview with Dr. Sylke Hassel, CEO
Discover the exclusive interview with Axplora's CEO, Sylke Hassel at CPHI Worldwide 2023. In this in-depth discussion, Sylke highlights the recent appointments of Stephan Haitz and Pere Paton Morales, key players in Axplora's journey towards innovation and growth.
News
October 02, 2023
A leading manufacturer of active, life-saving pharmaceutical ingredients: Axplora
“Sustainability and greener technologies are integral to our innovation approach; we proactively offer multiple sustainable options and technologies to our customers.” Created from the merger of Farmabios, Novasep, and PharmaZell, Axplora is a leading Active Pharmaceutical Ingredient (API) manufacturing partner, delivering high-quality active ingredients on time and at scale. Leveraging its combined expertise and manufacturing […]
Partner with us today
Clear your path to launch. Contact our technical experts to manage project complexities and secure your route to market.